Pharmaceutical stocks are widely regarded for their huge potential, but they come with risks. We cover how to find the best ...

India, May 31 -- As global geopolitical tensions continue to rise, ensuring resilience in interconnected systems ...

The drug and biotech sector has shown encouraging signs of recovery in 2026, driven by strong quarterly performances, ...

China's booming pharmaceutical industry is not being impacted by Beijing's ‌tightening scrutiny over deals involving ...

With China's growing dominance in the biopharma sector as a hotspot for drug asse | A group of over 20 global pharma leaders ...

Obesity assets represent about 25% of total forecast sales of the late-stage pipeline, while oncology's share has slipped to 20%, Deloitte found.

AstraZeneca's Clean Heat Program is turning industrial heat decarbonization into a hedge against energy volatility — and a ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — European policymakers on ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges. With a market value exceeding $280 ...

In contrast, the NSE IT index was trading at 17x compared with its FY26 average of 22.7x, while FMCG traded at 29.5x against ...

Pharmaceutical companies breathed a sigh of relief Wednesday after U.S. President Donald Trump revealed that they would not be subject to reciprocal tariffs — but that reprieve could prove fleeting.

The pharma sector to gain from currency tailwinds in the near term, with a weaker rupee acting as a key earnings driver, even as companies contend with cost pressures and evolving global demand. A ...